biote Corp. (BTMD) Research

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

Market snapshot

Symbol
BTMD
Price
$2.26
Day change
-0.44%
Market cap
$99.7M
P/E ratio
4.44x
52-week range
1.27-4.75
Sector
Healthcare
Industry
Medical - Care Facilities
Next earnings
in 2 months
Analyst price target
$3.25

Peer companies

  • Acumen Pharmaceuticals, Inc. (ABOS)
  • Actuate Therapeutics Inc (ACTU)
  • Anika Therapeutics, Inc. (ANIK)
  • Inovio Pharmaceuticals, Inc. (INO)
  • The Joint Corp. (JYNT)
  • Lucid Diagnostics Inc. (LUCD)
  • Seres Therapeutics, Inc. (MCRB)
  • Scilex Holding Company (SCLX)

Recent insider activity

  • Peterson Robert Charles — A-Award (206746 shares) on 2026-06-12
  • Christensen Bret — A-Award (130000 shares) on 2026-06-08
  • Beer Marc D — A-Award (114157 shares) on 2026-06-08
  • HEYER ANDREW R — A-Award (130000 shares) on 2026-05-12
  • HEYER ANDREW R — A-Award (35259 shares) on 2026-05-12

Open biote Corp. (BTMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.